HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
about
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imagingMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Radioactive Nanomaterials for Multimodality ImagingBionanotechnology and the future of glioma.Nanoparticles for Improving Cancer Diagnosis.Manganese-based MRI contrast agents: past, present and future.Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging.Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cellsPolyaspartic acid coated manganese oxide nanoparticles for efficient liver MRIDifferential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma.Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapyTransferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticlesL-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.The manipulation of natural killer cells to target tumor sites using magnetic nanoparticlesRadio-nanomaterials for biomedical applications: state of the artSurface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells.Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity.Nanoparticle-based multimodal PET/MRI probes.Nanomaterial-based activatable imaging probes: from design to biological applications.Core-shell NaGdF4@CaCO3 nanoparticles for enhanced magnetic resonance/ultrasonic dual-modal imaging via tumor acidic micro-enviroment triggering.A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Ultrasmall biomolecule-anchored hybrid GdVO4 nanophosphors as a metabolizable multimodal bioimaging contrast agent.Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.Application of nanoparticles on diagnosis and therapy in gliomas.Paramagnetic inorganic nanoparticles as T1 MRI contrast agents.In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.The effect of iron nanoparticles on performance of cognitive tasks in rats.Green synthesis of multimodal 'OFF-ON' activatable MRI/optical probes.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.
P2860
Q22064299-535CE999-7A27-4B77-94FC-40F48008B2DAQ26796475-D1EFC22A-9561-46F3-BEEB-E900C9366F0BQ28833646-F7DBA2DF-90F9-466B-B851-77B5474A1905Q30417964-EFC72FFF-CC09-4FB6-BFCA-6AE8F525BAABQ30442412-2C0792C1-9402-40BD-8CEE-74E25645CF23Q30461349-BBBBBB73-5C5A-4096-AE95-09E2A324DB96Q30564493-2C94A431-54CC-4BA8-8463-8BAD0D7539C0Q30620660-DBE5707C-9855-4AE0-A2CA-2090E1016A94Q30689242-536B4C0E-D996-43AF-87E8-BE92859A69C1Q30708177-26F5EE1D-2247-462C-844F-0C7F7A76CF66Q33818503-C3549B55-B5B6-4ACE-B48A-BAD00C57FCF8Q34069386-B3CF1335-7433-4D8E-82B7-E8CC8968254EQ34768493-0CC7E65F-92EE-478E-BF44-AEFCD261423DQ35194685-59D8F427-98BD-492A-8D5C-C8169CC6C422Q35624123-95B9DAFE-583B-460E-A91B-F6D249BF8AA3Q35687164-B099B3CD-FA8C-484B-8837-6AF59342FE84Q35855865-B9D930D3-FCCC-4CA0-B10F-0A0606C26D56Q36042421-72E7E187-767D-4370-8401-CD1A9BC06A58Q36607583-6C5B78A6-DA65-465E-A436-09A1EC37D2DEQ37131224-7C4BD05C-A269-4C39-83D8-CBDB79200390Q37676088-E9D5E1B3-3F17-47F9-A79E-DF0E8CE26CFEQ37848104-8647588A-0E93-4308-9A50-13721CF341AAQ38003151-70F8C76C-50F0-4278-B9F0-4F37813A111DQ38467265-C8561749-872D-47F0-9E84-01870DF94E1BQ38555053-3275BB6A-BED0-4EB0-B2E6-A80231AAE120Q38657299-34A62026-035F-4392-BD1E-BBD045FDDCD0Q38833531-2F681D23-D829-4D6A-8731-D19C2E18FD3AQ38898118-DFE55E67-D124-4A1D-A5C5-A048C063D04BQ38926681-C36D7E05-ACA2-4E65-B026-6B9117C58993Q38960148-38A0C802-7527-48A5-A56F-C10540ADEBEBQ39093063-CB136F43-9DAE-4F65-AFC0-E22A507AB6C7Q43142557-A9CF1D75-F4B1-41B7-A427-B4F2D10FC594Q43165459-F05E5375-A1D2-4F31-8517-B75119840EC4Q45848579-DF022E11-25C1-4512-A31E-C65C56B4E99EQ47258388-21D58620-A1C7-46D8-8EA8-5F7182625510Q47447811-B40C8916-9106-4FB7-80D8-FE9E32782F34Q47589446-94185566-3CF4-4285-90D4-AC593930F5DAQ48304626-6002E872-B337-47A3-8559-E621413EA674Q48971092-6031D8EB-DA2C-4052-8D1E-C443E4907A86Q55073008-BEF1A109-E838-4C67-B9DD-E7895D49CDDE
P2860
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@ast
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@en
type
label
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@ast
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@en
prefLabel
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@ast
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@en
P2093
P2860
P356
P1476
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
@en
P2093
P2860
P304
P356
10.1039/C0CC01041C
P407
P577
2010-08-23T00:00:00Z